0001104659-24-048343.txt : 20240417
0001104659-24-048343.hdr.sgml : 20240417
20240417163158
ACCESSION NUMBER: 0001104659-24-048343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240405
FILED AS OF DATE: 20240417
DATE AS OF CHANGE: 20240417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lizak Carol R.
CENTRAL INDEX KEY: 0001785794
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36714
FILM NUMBER: 24851538
MAIL ADDRESS:
STREET 1: 201 MISSION STREET, SUITE 2375
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jaguar Health, Inc.
CENTRAL INDEX KEY: 0001585608
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PINE STREET SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-371-8300
MAIL ADDRESS:
STREET 1: 200 PINE STREET SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
FORMER COMPANY:
FORMER CONFORMED NAME: Jaguar Animal Health, Inc.
DATE OF NAME CHANGE: 20130830
4
1
tm2411853-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-04-05
0
0001585608
Jaguar Health, Inc.
JAGX
0001785794
Lizak Carol R.
C/O JAGUAR HEALTH, INC.
200 PINE STREET, SUITE 400
SAN FRANCISCO
CA
94104
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-04-05
4
M
0
60
A
611
D
Common Stock
106
I
See footnote
Restricted stock units
2024-04-05
4
A
0
60
0
D
Common Stock
60
0
D
Restricted stock units convert into common stock on a one-for-one basis.
On January 23, 2023, the issuer effected a 75-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "January 2023 Reverse Stock Split). Upon effectiveness of the January 2023 Reverse Stock Split, every 75 shares of voting common stock was automatically converted into one share of voting common stock. On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "September 2021 Reverse Stock Split"). Upon effectiveness of the September 2021 Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
The restricted stock units were previously reported as covering 40,625 shares, but were adjusted to reflect the September 2021 Reverse Stock Split and January 2023 Reverse Stock Split. Such restricted stock units were granted on April 5, 2021 and vest in three equal annual installments beginning on April 5, 2022, the first anniversary of the grant date.
Securities held directly by the Peter & Carol Lizak Revocable Trust. Ms. Lizak, by virtue of her position as a co-trustee and beneficiary of such trust and her sharing of voting and investment control over the securities held by the trust with her spouse, may be deemed to beneficially own the securities held by the Peter & Carol Lizak Trust for purposes of Section 16.
/s/ Carol R. Lizak
2024-04-17